Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer

Journal of the National Cancer Institute

Volumn 99, Issue 17, 2007, Pages 1313-1327

  Singh, Lisam Shanjukumar ^a,b   Berk, Michael ^b   Oates, Rhonda ^c   Zhao, Zhenwen ^b   Tan, Haiyan ^b   Jiang, Ying ^b   Zhou, Aimin ^d   Kirmani, Kashif ^a   Steinmetz, Rosemary ^a   Lindner, Daniel ^c   Xu, Yan ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c TAUSSIG CANCER INSTITUTE   (United States)

^d CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROFORM; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 1; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; METHANOL; PERTUSSIS TOXIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER MORTALITY; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; GENE OVEREXPRESSION; HEAT SENSITIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MALE; MASS SPECTROMETRY; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; DNA PRIMERS; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM METASTASIS; PLASMIDS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 34548587161     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djm107     Document Type: Article

References (48)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics. CA Cancer J Clin 2006;56:106-30.
2. Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M. Metastasis suppressor genes: Basic biology and potential clinical use. Clin Breast Cancer 2003;4:51-62.
3. Steeg PS. Perspectives on classic article: Metastasis suppressor genes. J Natl Cancer Inst 2004;96:E4.
4. Shevde LA, Welch DR. Metastasis suppressor pathways - an evolving paradigm. Cancer Lett 2003;198:1-20.
5. Yoshida BA, Sokoloff MM, Welch DR, Rinker-Schaeffer CW. Metastasis-suppressor genes: A review and perspective on an emerging field. J Natl Cancer Inst 2000;92:1717-30.
6. Jiang Y, Berk M, Singh LS, Tan H, Yin L, Powell CT, et al. KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha. Clin Exp Metastasis 2005;22:369-76.
7. Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 2003;3:55-63.
8. Winter SF, Cooper AB, Greenberg NM. Models of metastatic prostate cancer: A transgenic perspective. Prostate Cancer Prostatic Dis 2003;6: 204-11.
9. Kue PF, Taub JS, Harrington LB, Polakiewicz RD, Ullrich A, Daaka Y. Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells. Int J Cancer 2002;102:572-9.
10. Yowell CW, Daaka Y. G protein-coupled receptors provide survival signals in prostate cancer. Clin Prostate Cancer 2002;1:177-81.
11. Kue PF, Daaka Y. Essential role for G proteins in prostate cancer cell growth and signaling. J Urol 2000;164:2162-7.
12. Behan DP, Chalmers DT. The use of constitutively active receptors for drug discovery at the G protein-coupled receptor gene pool. Curr Opin Drug Discov Devel 2001;4:548-60.
13. Xu Y, Casey G. Identification of human OGR1, a novel G protein-coupled receptor that maps to chromosome 14. Genomics 1996;35:397-402.
14. Qiao J, Huang F, Naikawadi RP, Kim KS, Said T, Lum H. Lysophosphatidylcholine impairs endothelial barrier function through the G Protein-coupled receptor, GPR4. Am J Physiol Lung Cell Mol Physiol 2006;291:L91-101.
15. Kim KS, Ren J, Jiang Y, Ebrahem. Q, Tipps R, Cristina K, et al. GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine. Faseb J 2005;19:819-21.
16. Tosa N, Murakami M, Jia WY, Yokoyama M, Masunaga T, Iwabuchi C, et al. Critical function of T cell death-associated gene 8 in glucocorticoid-induced thymocyte apoptosis. Int Immunol 2003;15:741-9.
17. Radu CG, Nijagal A, McLaughlin J, Wang L, Witte ON. Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. Proc Natl Acad Sci U S A 2005; 102:1632-7.
18. Im DS, Heise CE, Nguyen T, O'Dowd BF, Lynch KR. Identification of a molecular target of psychosine and its role in globoid cell formation. J Cell Biol 2001;153:429-34.
19. Im DS. Two ligands for a GPCR, proton vs lysolipid. Acts Pharmacol Sin 2005;26:1435-41.
20. Tomura H, Mogi C, Sato K, Okajima F. Proton-sensing and lysolipid-sensitive G-protein-coupled receptors: A novel type of multi-functional receptors. Cell Signal 2005;17:1466-76.
21. Seifert R, Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: Cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 2002;366:381-416.
22. Nordhoff V, Gromoll J, Simoni M. Constitutively active mutations of G protein-coupled receptors: The case of the human luteinizing hormone and follicle-stimulating hormone receptors. Arch Med Res 1999;30:501-9.
23. Boddy JL, Fox SB, Han C, Campo L, Turley H, Kanga S, et al. The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer. Clin Cancer Res 2005;11:7658-63.
24. LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V, et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 2002;62:4499-506.
25. Ludwig MG, Vanek M, Guerini D, Gasser JA, Jones CE, Junket U, et al. Proton-sensing G-protein-coupled receptors. Nature 2003;425:93-8.
26. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-7.
27. Schmidt R, Coste O, Geisslinger G. LC-MS/MS-analysis of prostaglandin E2 and D2 in microdialysis samples of rats. J Chromatogr B Analyt Technol Biomed Life Sci 2005;826:188-97.
28. Xiao YJ, Schwartz B, Washington M, Kennedy A, Webster K, Belinson J, et al. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: Comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids. Anal Biochem 2001;290:302-13.
29. Xiao Y, Chen Y, Kennedy AW, Belinson J, Xu Y. Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) anayles. Ann N Y Acad Sci 2000;905: 242-59.
30. Shevrin DH, Kukreja SC, Ghosh L, Lad TE. Development of skeletal metastasis by human prostate cancer in athymic nude mice. Clin Exp Metastasis 1988;6:401-9.
31. Bastide C, Bagnis C, Mannoni P, Hassoun J, Bladou F. A Nod Scid mouse model to study human prostate cancer. Prostate Cancer Prostatic Dis 2002;5: 311-5.
32. Rembrink K, Remijn JC, van der Kwast TH, Rubben H, Schroder FH. Orthetopic implantation of human prostate cancer cell lines a clinically relevant animal model for metastatic prostate cancer. Prostate 1997; 31:168-74.
33. Lin P, Ye RD. The lysophospholipid receptor G2A activates a specific combination of G proteins and promotes apoptosis. J. Biol Chem 2003; 278:14379-86.
34. Radu CG, Yang LV, Riedinger M, Au M, Witte ON. T cell chemotaxis to lysophosphatidylcholine through the G2A receptor. Proc Natl Acad Sci U S A 2004;101:245-50.
35. Bektas M, Barak LS, Jolly PS, Liu H, Lynch KR, Lacana E, et al. The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner. Biochemistry 2003;42:12181-91.
36. Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim. Biophys Acta 2002;1582:81-8.
37. Xu Y, Xiao YJ, Zhu K, Baudhuin LM, Lu J, Hong G, et al. Unfolding the pathophysiological role of bioactive lysophospholipids. Curr Drug Targets Immune Endocr Metabol Disord 2003;3:23-32.
38. Sin WC, Zhang Y, Zhong W, Adhikarakunnathu S, Powers S, Hoey T, et al. G protein-coupled receptors GPR4 and TDAG8 are oncogenic and overexpressed in human cancers. Oncogene 2004;23:6299-303.
39. Kalliomaki T, Hill RP. Effects of tumour acidification with glucose-MIBG on the spontaneous metastatic potential of two murine cell lines. Br J Cancer 2004;90:1842-9.
40. Iwai K, Koike M, Ohshima S, Miyatake K, Uchiyama Y, Saeki Y, et al. RGS18 acts as a negative regulator of osteoclastogenesis by modulating acid-sensing OGR1/NFAT signaling pathway. J Bone Miner Res 2007. [Jun 18 Epub ahead of print].
41. Yang M, Mailhot G, Birnbaum MJ, Mackay CA, Mason-Savas A, Odgren PR. Expression of and role for ovarian cancer G-protein-coupled receptor 1 (OGR1) during osteoclastogenesis. J Biol Chem 2006;281:23598-605.
42. Mogi C, Tomura H, Tobo M, Wang JQ, Damirin A, Kon J, et al. Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation. J Pharmacol. Sci 2005;99:160-7.
43. Garcia-Fernandez MO, Solano RM, Sanchez-Chapado M, Ruiz-Villaespesa A, Prieto JC, Carmena MJ. Low expression of Galpha protein subunits in human prostate cancer. J Urol 2001;166:2512-7.
44. Panetti TS. Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells. Biochim Biophys Acta 2002;1582: 190-6.
45. Sugimoto N, Takuwa N, Yoshioka K, TakuwaRho-dependent Y. Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells. Exp Cell Res 2006;312:1899-908.
46. Sugimoto N, Takuwa N, Okamoto H, Sakurada S, Takuwa Y. Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol 2003;23:1534-45.
47. Liu F, Verin AD, Wang P, Day R, Wersto RP, Chrest FJ, et al. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha.2)-linked Rho kinase activity. Am J Respir Cell Mol Biol 2001;24:711-9.
48. Mooradian DL, Fernandes B, Diglio CA, Lester BR. Angiopeptin (BIM23014C) inhibits vascular smooth muscle cell migration in vitro through a G-protein-mediated pathway and is associated with inhibition of adenylyl cyclase and cyclic AMP accumulation. J Cardiovasc Pharmacol 1995;25:611-8.